Andrew Kambugu
#74,881
Most Influential Person Now
Ugandan physician
Andrew Kambugu's AcademicInfluence.com Rankings
Andrew Kambuguphilosophy Degrees
Philosophy
#10723
World Rank
#14712
Historical Rank
Logic
#8513
World Rank
#10669
Historical Rank
Download Badge
Philosophy
Andrew Kambugu's Degrees
- Bachelors Medicine Makerere University
- Masters Internal Medicine Makerere University
- PhD Medicine University of Cape Town
Why Is Andrew Kambugu Influential?
(Suggest an Edit or Addition)According to Wikipedia, Andrew Ddungu Kambugu is a Ugandan physician who serves as The Sande-McKinnell Executive Director at Uganda Infectious Disease Institute and a Honorary Senior lecturer at Makerere University College of Sciences. He is also an Adjunct Associate Professor at the University of Minnesota. In July 2020, he was appointed to the United Nations 2021 Food System Scientific Group.
Andrew Kambugu's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. (2014) (372)
- Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy. (2008) (282)
- Retention in Care among HIV-Infected Patients in Resource-Limited Settings: Emerging Insights and New Directions (2010) (278)
- Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings. (2010) (277)
- Clinical Features and Serum Biomarkers in HIV Immune Reconstitution Inflammatory Syndrome after Cryptococcal Meningitis: A Prospective Cohort Study (2010) (249)
- Predictors of Long-Term Viral Failure Among Ugandan Children and Adults Treated With Antiretroviral Therapy (2007) (237)
- Assessment of second-line antiretroviral regimens for HIV therapy in Africa. (2014) (183)
- Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome. (2010) (175)
- Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy. (2008) (159)
- Immunodeficiency at the Start of Combination Antiretroviral Therapy in Low-, Middle-, and High-Income Countries (2013) (149)
- Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort. (2009) (133)
- Retention in Care and Patient-Reported Reasons for Undocumented Transfer or Stopping Care Among HIV-Infected Patients on Antiretroviral Therapy in Eastern Africa: Application of a Sampling-Based Approach. (2016) (124)
- Tuberculosis immune reconstitution inflammatory syndrome in countries with limited resources. (2006) (121)
- Belief in divine healing can be a barrier to antiretroviral therapy adherence in Uganda (2007) (108)
- Palliative care in sub-Saharan Africa (2005) (102)
- Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in Africa (2014) (99)
- Cryptococcal Genotype Influences Immunologic Response and Human Clinical Outcome after Meningitis (2012) (85)
- Incident Tuberculosis during Antiretroviral Therapy Contributes to Suboptimal Immune Reconstitution in a Large Urban HIV Clinic in Sub-Saharan Africa (2010) (84)
- Assessing the impact of delivering messages through intimate partners to create demand for voluntary medical male circumcision in Uganda (2016) (81)
- Estimation of mortality among HIV-infected people on antiretroviral treatment in East Africa: a sampling based approach in an observational, multisite, cohort study. (2015) (78)
- Short Message Service (SMS)-Based Intervention to Improve Treatment Adherence among HIV-Positive Youth in Uganda: Focus Group Findings (2015) (74)
- Implementation of Provider-Based Electronic Medical Records and Improvement of the Quality of Data in a Large HIV Program in Sub-Saharan Africa (2012) (68)
- Text Messaging for Improving Antiretroviral Therapy Adherence: No Effects After 1 Year in a Randomized Controlled Trial Among Adolescents and Young Adults (2017) (65)
- Potential impact of task-shifting on costs of antiretroviral therapy and physician supply in Uganda (2009) (64)
- Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial (2017) (60)
- Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial (2017) (60)
- Predicting the Impact of COVID-19 and the Potential Impact of the Public Health Response on Disease Burden in Uganda (2020) (58)
- Subclinical Atherosclerosis among HIV-Infected Adults Attending HIV/AIDS Care at Two Large Ambulatory HIV Clinics in Uganda (2014) (56)
- Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV. (2021) (53)
- Alcohol Consumption among HIV-Infected Persons in a Large Urban HIV Clinic in Kampala Uganda: A Constellation of Harmful Behaviors (2015) (52)
- HIV serostatus disclosure and lived experiences of adolescents at the Transition Clinic of the Infectious Diseases Clinic in Kampala, Uganda: A qualitative study (2012) (52)
- Gender Differences in Clinical Presentation and Outcomes of Epidemic Kaposi Sarcoma in Uganda (2010) (51)
- Development and evaluation of a clinical algorithm to monitor patients on antiretrovirals in resource-limited settings using adherence, clinical and CD4 cell count criteria (2009) (50)
- Cost Effectiveness of a Pharmacy-Only Refill Program in a Large Urban HIV/AIDS Clinic in Uganda (2011) (48)
- Evaluation of Filter Paper Transfer of Whole-Blood and Plasma Samples for Quantifying HIV RNA in Subjects on Antiretroviral Therapy in Uganda (2007) (48)
- Detection of tuberculosis patterns in digital photographs of chest X-ray images using Deep Learning: feasibility study. (2018) (47)
- Atorvastatin reduces T-cell activation and exhaustion among HIV-infected cART-treated suboptimal immune responders in Uganda: a randomised crossover placebo-controlled trial (2015) (46)
- A prospective ascertainment of cancer incidence in sub‐Saharan Africa: The case of Kaposi sarcoma (2016) (45)
- The spectrum of liver diseases in HIV infected individuals at an HIV treatment clinic in Kampala, Uganda. (2008) (44)
- Cellular Immune Activation in Cerebrospinal Fluid From Ugandans With Cryptococcal Meningitis and Immune Reconstitution Inflammatory Syndrome (2014) (44)
- Peer distribution of HIV self-test kits to men who have sex with men to identify undiagnosed HIV infection in Uganda: A pilot study (2020) (42)
- Facility-Level Factors Influencing Retention of Patients in HIV Care in East Africa (2016) (42)
- Is Urinary Lipoarabinomannan the Result of Renal Tuberculosis? Assessment of the Renal Histology in an Autopsy Cohort of Ugandan HIV-Infected Adults (2015) (41)
- Cryptococcal disease and the burden of other fungal diseases in Uganda; Where are the knowledge gaps and how can we fill them? (2015) (38)
- Improvement of the patient flow in a large urban clinic with high HIV seroprevalence in Kampala, Uganda (2009) (37)
- HIV-Associated Cryptococcal Meningitis Occurring at Relatively Higher CD4 Counts (2018) (37)
- Sexual Behaviors Over a 3-Year Period Among Individuals With Advanced HIV/AIDS Receiving Antiretroviral Therapy in an Urban HIV Clinic in Kampala, Uganda (2011) (36)
- Optimizing antimicrobial use: challenges, advances and opportunities (2021) (36)
- Symptomatic hyperlactatemia associated with nucleoside analogue reverse-transcriptase inhibitor use in HIV-infected patients: a report of 24 cases in a resource-limited setting (Uganda). (2007) (36)
- Delayed Sputum Culture Conversion in Tuberculosis–Human Immunodeficiency Virus–Coinfected Patients With Low Isoniazid and Rifampicin Concentrations (2018) (35)
- Optimising antimicrobial use in humans – review of current evidence and an interdisciplinary consensus on key priorities for research (2021) (35)
- Antiretroviral Treatment-Associated Tuberculosis in a Prospective Cohort of HIV-Infected Patients Starting ART (2010) (35)
- Uganda’s experience in Ebola virus disease outbreak preparedness, 2018–2019 (2020) (35)
- Using a clinic based creativity initiative to reduce HIV related stigma at the Infectious Diseases Institute, Mulago National Referral Hospital, Uganda. (2012) (34)
- Acceptability, perceived reliability and challenges associated with distributing HIV self‐test kits to young MSM in Uganda: a qualitative study (2019) (34)
- Worsening and unmasking of tuberculosis in HIV-1 infected patients after initiating highly active anti-retroviral therapy in Uganda. (2008) (33)
- Immune reconstitution disease of the central nervous system (2008) (33)
- Standardized Electrolyte Supplementation and Fluid Management Improves Survival During Amphotericin Therapy for Cryptococcal Meningitis in Resource-Limited Settings (2014) (31)
- Needle Autopsy to Establish the Cause of Death in HIV-Infected Hospitalized Adults in Uganda: A Comparison to Complete Autopsy (2014) (31)
- Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial (2018) (30)
- Ten years of antiretroviral therapy: Incidences, patterns and risk factors of opportunistic infections in an urban Ugandan cohort (2018) (30)
- Peripheral neuropathy in HIV patients in sub-Saharan Africa failing first-line therapy and the response to second-line ART in the EARNEST trial (2016) (30)
- Response to 'Does immune reconstitution promote active tuberculosis in patients receiving highly active antiretroviral therapy?' AIDS, 22 July 2005. (2005) (30)
- Frequency and impact of suboptimal immune recovery on first-line antiretroviral therapy within the International Epidemiologic Databases to Evaluate AIDS in East Africa (2016) (29)
- Symptomatic Cryptococcal Antigenemia Presenting as Early Cryptococcal Meningitis With Negative Cerebral Spinal Fluid Analysis. (2018) (29)
- Patient-reported factors associated with reengagement among HIV-infected patients disengaged from care in East Africa (2015) (28)
- Accuracy of Lipoarabinomannan and Xpert MTB/RIF Testing in Cerebrospinal Fluid To Diagnose Tuberculous Meningitis in an Autopsy Cohort of HIV-Infected Adults (2015) (28)
- Essential in vitro diagnostics for advanced HIV and serious fungal diseases: international experts’ consensus recommendations (2019) (27)
- Earlier initiation of antiretroviral therapy, increased tuberculosis case finding and reduced mortality in a setting of improved HIV care: a retrospective cohort study (2012) (27)
- Task Shifting and Skin Punch for the Histologic Diagnosis of Kaposi's Sarcoma in Sub-Saharan Africa: A Public Health Solution to a Public Health Problem (2015) (26)
- Early virological failure and HIV drug resistance in Ugandan adults co-infected with tuberculosis (2017) (26)
- Mortality and Immunological Recovery Among Older Adults on Antiretroviral Therapy at a Large Urban HIV Clinic in Kampala, Uganda (2014) (26)
- The medical management of central nervous system infections in Uganda and the potential impact of an algorithm-based approach to improve outcomes. (2007) (26)
- The epidemiology and clinical correlates of HIV-1 co-receptor tropism in non-subtype B infections from India, Uganda and South Africa (2012) (25)
- Virologic versus immunologic monitoring and the rate of accumulated genotypic resistance to first-line antiretroviral drugs in Uganda (2012) (25)
- Outcomes in a Cohort of Patients Started on Antiretroviral Treatment and Followed up for a Decade in an Urban Clinic in Uganda (2015) (24)
- Comparison of Methods for Correction of Mortality Estimates for Loss to Follow-Up after ART Initiation: A Case of the Infectious Diseases Institute, Uganda (2013) (24)
- Elevated Aspergillus-specific antibody levels among HIV infected Ugandans with pulmonary tuberculosis (2017) (24)
- First-line antiretroviral therapy in Africa--how evidence-base are our recommendations? (2005) (24)
- Antiretroviral Therapy Down-Regulates Innate Antiviral Response Genes in Patients With AIDS in Sub-Saharan Africa (2010) (23)
- Socioeconomic position and ten-year survival and virologic outcomes in a Ugandan HIV cohort receiving antiretroviral therapy (2017) (23)
- Key bottlenecks to the provision of safe obstetric anaesthesia in low- income countries; a cross-sectional survey of 64 hospitals in Uganda (2017) (22)
- Low Antituberculosis Drug Concentrations in HIV-Tuberculosis-Coinfected Adults with Low Body Weight: Is It Time To Update Dosing Guidelines? (2019) (22)
- A Randomized Controlled Trial to Evaluate the Effectiveness of a Board Game on Patients' Knowledge Uptake of HIV and Sexually Transmitted Diseases at the Infectious Diseases Institute, Kampala, Uganda (2012) (21)
- First-line antiretroviral therapy durability in a 10-year cohort of naïve adults started on treatment in Uganda (2016) (21)
- A decade of antiretroviral therapy in Uganda: what are the emerging causes of death? (2019) (21)
- Sub-Optimal Vitamin B-12 Levels among ART-Naïve HIV-Positive Individuals in an Urban Cohort in Uganda (2012) (20)
- High CD56++CD16- natural killer (NK) cells among suboptimal immune responders after four years of suppressive antiretroviral therapy in an African adult HIV treatment cohort (2014) (19)
- Urban Movement and Alcohol Intake Strongly Predict Defaulting from Tuberculosis Treatment: An Operational Study (2012) (19)
- High rate of misclassification of treatment failure based on WHO immunological criteria. (2009) (18)
- Untangling the Relationship Between Antiretroviral Therapy Use and Incident Pregnancy: A Marginal Structural Model Analysis Using Data From 47,313 HIV-Positive Women in East Africa (2016) (18)
- Neurocognitive function in HIV-infected persons with asymptomatic cryptococcal antigenemia: a comparison of three prospective cohorts (2017) (17)
- Which HIV patients should be screened for osteoporosis: an international perspective (2016) (17)
- Capacity for science in sub-Saharan Africa (2015) (17)
- The Causal Effect of Tracing by Peer Health Workers on Return to Clinic Among Patients Who Were Lost to Follow-up From Antiretroviral Therapy in Eastern Africa: A “Natural Experiment” Arising From Surveillance of Lost Patients (2017) (16)
- A need to accelerate health research productivity in an African University: the case of Makerere University College of Health Sciences (2017) (16)
- Innovative Demand Creation for Voluntary Medical Male Circumcision Targeting a High Impact Male Population: A Pilot Study Engaging Pregnant Women at Antenatal Clinics in Kampala, Uganda (2016) (15)
- Clinical presentation and aetiologies of acute or complicated headache among HIV-seropositive patients in a Ugandan clinic (2009) (15)
- Characteristics of Sexually Transmitted Infections among High-Risk HIV-Positive Patients Attending an Urban Clinic in Uganda (2016) (14)
- Measuring the Outcomes of a Comprehensive HIV Care Course: Pilot Test at the Infectious Diseases Institute, Kampala, Uganda (2006) (14)
- Transitioning behaviourally infected HIVpositive young people into adult care: Experiences from the young person’s point of view (2013) (14)
- Anti-TB drug concentrations and drug-associated toxicities among TB/HIV-coinfected patients (2017) (14)
- Tuberculosis treatment success among rural and urban Ugandans living with HIV: a retrospective study. (2017) (14)
- Determinants of utilization of a no-cost HIV transition clinic: a cross-sectional study of young adults living with HIV/AIDS (2013) (13)
- A public health approach to cervical cancer screening in Africa through community‐based self‐administered HPV testing and mobile treatment provision (2019) (13)
- Challenges in Diagnosis, Treatment and Follow-up of Patients Presenting with Central Nervous System Infections in a Resource-Limited Setting (2006) (13)
- Effect of emergency major abdominal surgery on CD4 cell count among HIV positive patients in a sub Saharan Africa tertiary hospital - a prospective study (2013) (13)
- A Pharmacy-Only Refill Program at a Large HIV Clinic in Uganda (2014) (12)
- A Social-Ecological Framework to Understand Barriers to HIV Clinic Attendance in Nakivale Refugee Settlement in Uganda: a Qualitative Study (2020) (12)
- Bending the Arc towards Equitable Partnerships in Global Health and Applied Training (2019) (12)
- Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of first-line recommended ACT (QUINACT): a bicentre, open-label, phase 3, randomised controlled trial. (2017) (12)
- Factors before enrolment are associated with being removed from a Pharmacy-only Refill Programme at a large urban HIV/AIDS clinic, Uganda (2014) (12)
- Lipid levels, insulin resistance and cardiovascular risk over 96 weeks of antiretroviral therapy: a randomised controlled trial comparing low-dose stavudine and tenofovir (2018) (12)
- The utility of pharmacokinetic studies for the evaluation of exposure-response relationships for standard dose anti-tuberculosis drugs. (2018) (12)
- HIV-1 Drug Resistance Among Ugandan Adults Attending an Urban Out-Patient Clinic (2018) (11)
- OUTCOMES OF CRYPTOCOCCAL MENINGITIS IN UGANDA BEFORE AND AFTER THE AVAILABILITY OF HAART (2008) (11)
- CD4+ T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and Africa (2015) (11)
- Estimation of Mortality among HIV-infected people on antiretroviral therapy treatment in east Africa: a sampling based approach in an observational, multisite, cohort study. (2015) (11)
- Challenges in achieving a target international normalized ratio for deep vein thrombosis among HIV-infected patients with tuberculosis: a case series (2016) (11)
- Initiation of antiretroviral therapy based on the 2015 WHO guidelines (2016) (11)
- Kaposi's sarcoma-associated immune reconstitution inflammatory syndrome (KS-IRIS) in Africa: initial findings from a prospective evaluation (2009) (11)
- Impact of NRTI Cross-Resistance on Second-line PI + NRTI Therapy Outcomes in Africa (2015) (11)
- Increased prevalence of pregnancy and comparative risk of program attrition among individuals starting HIV treatment in East Africa (2018) (11)
- High efavirenz serum concentrations in TB/HIV-coinfected Ugandan adults with a CYP2B6 516 TT genotype on anti-TB treatment (2018) (10)
- Low isoniazid and rifampicin concentrations in TB/HIV co-infected patients in Uganda (2014) (10)
- Engendering health systems in response to national rollout of dolutegravir-based regimens among women of childbearing potential: a qualitative study with stakeholders in South Africa and Uganda (2020) (10)
- A Pilot Test of Game Changers, a Social Network Intervention to Empower People with HIV to be Prevention Advocates in Uganda (2020) (9)
- Prevalence of viral load suppression, predictors of virological failure and patterns of HIV drug resistance after 12 and 48 months on first-line antiretroviral therapy: a national cross-sectional survey in Uganda (2020) (9)
- Low antigen-specific CD4 T-cell immune responses despite normal absolute CD4 counts after long-term antiretroviral therapy an African cohort. (2014) (9)
- Antiretroviral treatment Long-Term (ALT) cohort: a prospective cohort of 10 years of ART-experienced patients in Uganda (2018) (9)
- Evaluation of trypan blue stain in a haemocytometer for rapid detection of cerebrospinal fluid sterility in HIV patients with cryptococcal meningitis (2017) (9)
- Cohort profile of a study on outcomes related to tuberculosis and antiretroviral drug concentrations in Uganda: design, methods and patient characteristics of the SOUTH study (2017) (9)
- Risky sexual behavior among patients on long-term antiretroviral therapy: a prospective cohort study in urban and rural Uganda (2018) (9)
- Incidence rate of sexually transmitted infections among HIV infected patients on long-term ART in an urban and a rural clinic in Uganda (2019) (8)
- Pre-ART HIV resistance testing in Africa: are we there yet? (2012) (8)
- Immunology in Africa (2015) (8)
- Neurocognitive Function at the First-Line Failure and on the Second-Line Antiretroviral Therapy in Africa: Analyses From the EARNEST Trial (2016) (8)
- Macro level influences on strategic responses to the COVID-19 pandemic – an international survey and tool for national assessments (2021) (8)
- Frequency and Predictors for Late Start of Antiretroviral Therapy in Primary Care Clinics, Kampala, Uganda (2012) (8)
- Importance of routine viral load monitoring: higher levels of resistance at ART failure in Uganda and Lesotho compared with Switzerland (2018) (8)
- Correction of estimates of retention in care among a cohort of HIV-positive patients in Uganda in the period before starting ART: a sampling-based approach (2018) (8)
- Hazardous alcohol consumption is not associated with CD4+ T-cell count decline among PLHIV in Kampala Uganda: A prospective cohort study (2017) (8)
- Validation of a portable hand-held lactate analyzer for determination of blood lactate in patients on antiretroviral therapy in Uganda. (2008) (8)
- Community acceptability of dolutegravir-based HIV treatment in women: a qualitative study in South Africa and Uganda (2020) (7)
- Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized Trial (2018) (7)
- Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized Trial (2018) (7)
- Gastrointestinal cryptococcoma – Immune reconstitution inflammatory syndrome or cryptococcal relapse in a patient with AIDS? (2015) (7)
- Efficacy and Safety of Tenofovir Disoproxil Fumarate Versus Low-Dose Stavudine Over 96 Weeks: A Multicountry Randomized, Noninferiority Trial (2019) (7)
- Comparison of different cardiovascular risk tools used in HIV patient cohorts in sub-Saharan Africa; do we need to include laboratory tests? (2021) (7)
- CD4 T-cell activation and reduced regulatory T-cell populations are associated with early development of cataracts among HIV-infected adults in Uganda. (2014) (7)
- Inadequate Monitoring in Advanced Stages of Disease with Lack of Supportive Counseling Increases Attrition among Patients on Antiretroviral Treatment at a Large Urban Clinic in Uganda (2014) (7)
- Efficacy and Safety of Tenofovir Disoproxil Fumarate Versus Low-Dose Stavudine Over 96 Weeks: A Multicountry Randomized, Noninferiority Trial (2018) (6)
- Feasibility of Virtual Reality based Training for Optimising COVID-19 Case Handling in Uganda (2021) (6)
- Efficacy and safety of dolutegravir or darunavir in combination with lamivudine plus either zidovudine or tenofovir for second-line treatment of HIV infection (NADIA): week 96 results from a prospective, multicentre, open-label, factorial, randomised, non-inferiority trial. (2022) (6)
- Feasibility of a Short Message Service based intervention to improve adherence among HIV-positive youth in Uganda: a focus group study (2014) (6)
- Evaluation of trypan blue stain in the TC20 automated cell counter as a point-of-care for the enumeration of viable cryptococcal cells in cerebrospinal fluid (2018) (6)
- Hypertension and associated risk factors in individuals infected with HIV on antiretroviral therapy at an urban HIV clinic in Uganda (2014) (5)
- COVID-19 in Uganda: Predicting the impact of the disease and public health response on disease burden (2020) (5)
- Gaps in TB preventive therapy for persons initiating antiretroviral therapy in Uganda: an explanatory sequential cascade analysis. (2021) (5)
- Health Worker Perspectives on Barriers and Facilitators of Assisted Partner Notification for HIV for Refugees and Ugandan Nationals: A Mixed Methods Study in West Nile Uganda (2021) (4)
- Transitional Clinic Utilization and General Well Being of Ugandan Young Adults Living with HIV/AIDS. (2014) (4)
- Spectrum of antibiotic resistance in UTI caused by Escherichia coli among HIV-infected patients in Uganda: a cross-sectional study (2021) (4)
- Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa (2016) (4)
- Basis of selection of first and second line highly active antiretroviral therapy for HIV/AIDS on genetic barrier to resistance: a literature review. (2014) (4)
- Hepatitis B virus infection in adolescents and young adults with human immunodeficiency virus infection in an urban clinic in a resource‐limited setting (2012) (4)
- CD41 T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and Africa. (2015) (4)
- Non‐communicable diseases among elderly patients with human immunodeficiency virus infection at an urban clinic in a resource‐limited setting (2012) (4)
- Task shifting for initiation and monitoring of antiretroviral therapy for HIV-infected adults in Uganda: The SHARE Trial. (2020) (4)
- Strengthening the “Viral Failure Pathway”: Clinical Decision and Outcomes of Patients With Confirmed Viral Failure in a Large HIV Care Clinic in Uganda (2015) (3)
- Low bone mass in people living with HIV on long-term anti-retroviral therapy: A single center study in Uganda (2021) (3)
- Understanding the role of interpersonal violence in assisted partner notification for HIV: a mixed-methods study in refugee settlements in West Nile Uganda (2020) (3)
- Text Messaging for Improving Antiretroviral Therapy Adherence (2017) (3)
- Are the best antiretrovirals being used in Africa? (2006) (3)
- Ensuring Access to Safe and Nutritious Food for All Through Transformation of Food Systems (2021) (3)
- Significant rates of risky sexual behaviours among HIV-infected patients failing first-line ART: A sub-study of the Europe–Africa Research Network for the Evaluation of Second-line Therapy trial (2018) (3)
- The frequency distribution of vitamin D Receptor fok I gene polymorphism among Ugandan pulmonary TB patients (2016) (3)
- Using Media to Promote Public Awareness of Early Detection of Kaposi's Sarcoma in Africa (2019) (3)
- Does Cotrimoxazole Prophylaxis Improve Outcomes after ART Initiation in HIV-infected African Adults? A Causal Analysis Using Marginal Structural Models. (2008) (3)
- Antiretroviral concentration measurements as an additional tool to manage virologic failure in resource limited settings: a case control study (2019) (3)
- A rare entity of primary extranodal diffuse large B cell lymphoma of the lower limb calf in an HIV-infected young adult on highly active antiretroviral therapy (2012) (3)
- Immune reconstitution inflammatory syndrome among adolescents: A report of cases in a resource-limited setting (Uganda) (2010) (2)
- Afri-Can Forum 2 (2016) (2)
- Feasibility of Rapid Case Ascertainment for Cancer in East Africa: An Investigation of Community-Representative Kaposi Sarcoma in the Era of Antiretroviral Therapy. (2021) (2)
- Support for the response to COVID-19 in Uganda: contribution of the global health security program at Makerere University's Infectious Diseases Institute (2022) (2)
- Second-line treatment in sub-Saharan Africa: week 144 follow-up of the EARNEST trial (2015) (2)
- Implementation of WHO Global Antimicrobial Resistance Surveillance System in Uganda: National Surveillance Report, 2015 to 2020 (Preprint) (2021) (2)
- Implementation of the World Health Organization Global Antimicrobial Resistance Surveillance System in Uganda, 2015-2020: Mixed-Methods Study Using National Surveillance Data (2021) (2)
- Infectious Diseases Institute at Makerere University College of Health Sciences: a case study of a sustainable capacity building model for health care, research and training (2022) (2)
- Delayed sputum conversation in TB-HIV co-infected patients with low isoniazid and rifampicin concentrations (2017) (2)
- A case of palatal perforation caused by toxoplasmosis (2010) (2)
- AIDS-associated Kaposi sarcoma in Uganda: response to treatment with highly active antiretroviral therapy and chemotherapy (2009) (2)
- International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK (2016) (2)
- Examination of Mediators and Moderators to Understand How and in What Context Game Changers Increases HIV Prevention Advocacy Among Persons Living With HIV in Uganda (2021) (2)
- Prevalence and risk factors for hypertension and diabetes among those screened in a refugee settlement in Uganda (2021) (2)
- Closing the Gap Toward Zero Tetanus Infection for Voluntary Medical Male Circumcision: Seven Case Reports and a Review of the Literature. (2020) (1)
- The necessity of incorporating gynaecological tests in antiretroviral therapy packages – case observations (2011) (1)
- Initial description of immune reconstitution inflammatory syndrome involving the thyroid gland in an immunocompromised patient (2011) (1)
- Macro Level Influences on Strategic Responses to the COVID-19 Pandemic - A Tool for National Assessments (2020) (1)
- Early discharge from hospital after caesarean section at Chris Hani Baragwanath Hospital : scientific letter, South African Journal of Obstetrics and Gynaecology, (17) 1 2011 : pp. 16-17 : : errata (2011) (1)
- Impact of community engagement and social support on the outcomes of HIV-related meningitis clinical trials in a resource-limited setting (2020) (1)
- Effi cacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of fi rst-line recommended ACT (QUINACT): a bicentre, open-label, phase 3, randomised controlled trial (2017) (1)
- Unmet needs persist in pediatric HIV programs: lessons from selected case studies in Uganda. (2017) (1)
- A Case report: Herpes zooster IRIS in pregnancy. (2009) (1)
- Baseline Xpert MTB/RIF ct values predict sputum conversion during the intensive phase of anti-TB treatment in HIV infected patients in Kampala, Uganda: a retrospective study (2021) (1)
- Using Intervention Mapping methodology to design an HIV linkage intervention in a refugee settlement in rural Uganda (2021) (1)
- Investigating the Impediments to Accessing Reliable, Timely and Integrated Electronic Patient Data in Healthcare Sites in Uganda (2021) (1)
- Feasibility of virtual reality based training for optimising COVID-19 case handling in Uganda (2022) (1)
- Long Term Virological Outcomes of Hiv Infected Patients on Antiretroviral Treatment In Uganda. (2015) (1)
- Virological Outcome of Patients With HIV Drug Resistance Attending an Urban Outpatient Clinic in Uganda: A Need for Structured Adherence Counseling and Third-Line Treatment Options (2019) (1)
- Integrating hepatitis B care and treatment with existing HIV services is possible: cost of integrated HIV and hepatitis B treatment in a low-resource setting: a cross-sectional hospital-based cost-minimisation assessment (2022) (1)
- Peripheral neuropathy in HIV patients in sub-Saharan Africa failing first-line therapy and the response to second-line ART in the EARNEST trial (2015) (1)
- PP122 Strengthening Ethics Compliance In A Large Research Program: Uganda (2017) (1)
- Bilateral pedal edema in an HIV patient: Lopinavir/Ritonavir-containing treatment regimen as a potential cause? (2009) (1)
- 95. Improved Retention in Care for Ugandan Youth Living With HIV Utilizing a Youth-Targeted Clinic at Entry to Adult Care: Outcomes and Implications for a Transition Model (2015) (1)
- Improving compliance to workplace prevention and control (IPC) measures during the COVID-19 pandemic in a non-healthcare setting (2021) (0)
- Chronic genital ulcer disease with subsequent development of methicillin-resistant Staphylococcus aureus (MRSA ) urethritis and bacteraemia in an HIV-seropositive person – A case observation (2012) (0)
- Eleventh International Congress on Drug Therapy in HIV Infection (2012) (0)
- Eleventh International Congress on Drug Therapy in HIV Infection (2012) (0)
- Establishing the State of Practice about Data Standards in Monitoring Healthcare Interventions for HIV in Uganda's EMR-based Health Information Systems (2021) (0)
- Feasibility and acceptability of integrating hepatitis B care into routine HIV services: a qualitative study among health care providers and patients in West Nile region, Uganda (2023) (0)
- Erratum for Sekaggya-Wiltshire et al., “Low Antituberculosis Drug Concentrations in HIV-Tuberculosis-Coinfected Adults with Low Body Weight: Is It Time To Update Dosing Guidelines?” (2020) (0)
- Principles of Medicine in Africa: HIV/AIDS (2013) (0)
- 257 Does toxicity to fixed dose stavudine, lamivudine and nevirapine regimen affect virologic suppression among HIV infected adults at the Infectious Diseases Institute, Makerere University? (2009) (0)
- Ten Years Outcomes in a Cohort of Patients Started on Antiretroviral Treatment in an Urban Clinic in Sub-Saharan Africa. (2014) (0)
- Next-generation sequencing (NGS) reveals low-abundance HIV-1 drug resistance mutations among patients experiencing virological failure at the time of therapy switching in Uganda [version 1; peer review: awaiting peer review] (2022) (0)
- International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK (2014) (0)
- Mentoring for sustainable in-country academic leadership in resource-limited settings (2015) (0)
- Mental disorders and lack of social support among refugees and Ugandan nationals screening for HIV at health centers in Nakivale refugee settlement in southwestern Uganda (2022) (0)
- Essential in vitro diagnostics for advanced HIV and serious fungal diseases: international experts’ consensus recommendations (2019) (0)
- Neurocognitive function in patients failing first-line ART in Africa and responses to second-line (2015) (0)
- Implementation of the World Health Organization Global Antimicrobial Resistance Surveillance System in Uganda, 2015-2020: Mixed-Methods Study Using National Surveillance Data (Preprint) (2021) (0)
- Structured career development for global health research in resource-limited settings: A pilot of career development series for faculty at Makerere university college of health sciences (2015) (0)
- Use of antiretroviral therapy during pregnancy among HIV-infected women attending an urban care centre (2010) (0)
- PIN9 THE WORKFORCE AND COST IMPLICATIONS OF SUBSTITUTING NURSES AND PHARMACISTS FOR DOCTORS IN THE FOLLOW-UP OF PATIENTS WITH AIDS ON ANTIRETROVIRALTHERAPY IN UGANDA (2008) (0)
- WITHDRAWN: The Acute and early (<30 days) unmasking of tuberculosis by antiretroviral therapy in africa and other resource limited settings (2006) (0)
- Lipid levels, insulin resistance and cardiovascular risk over 96 weeks of antiretroviral therapy: a randomised controlled trial comparing low-dose stavudine and tenofovir (2018) (0)
- 'If at first you don't succeed, try again'. Looking beyond the initial results of a failed tuberculosis diagnosis. (2015) (0)
- Hyperglycaemia and pharmacokinetics of rifampicin/isoniazid among TB-HIV co-infected patients in Kampala, Uganda. (2020) (0)
- Repeated Artemisinin-based combination treatment and dynamics of Plasmodium falciparum strains in Uganda and the Democratic Republic of the Congo (2017) (0)
- Peripheral neuropathy at first-line failure and on second-line in sub-Saharan Africa (2015) (0)
- “You would not be in a hurry to go back home”: patients’ willingness to participate in HIV/AIDS clinical trials at a clinical and research facility in Kampala, Uganda (2020) (0)
- Treatment success of urban and rural Ugandans 101 Public Health Action (2018) (0)
- Risky sexual behavior among patients on long-term antiretroviral therapy: a prospective cohort study in urban and rural Uganda AIDS Research and Therapy (2019) (0)
- Adherence monitoring methods to measure virological failure in people living with HIV on long-term antiretroviral therapy in Uganda (2022) (0)
- Integrating Hepatitis B Care and Treatment with Existing HIV Services is Possible: A Cost Minimization Analysis from a Low Resource Setting. (2020) (0)
- High CD56++CD16- natural killer (NK) cells among suboptimal immune responders after four years of suppressive antiretroviral therapy in an African adult HIV treatment cohort (2014) (0)
- Response and Human Clinical Outcome after Meningitis Cryptococcal Genotype Influences Immunologic 2012 (2012) (0)
- Faculty Opinions recommendation of Aspirin attenuates platelet activation and immune activation in HIV-1-infected subjects on antiretroviral therapy: a pilot study. (2013) (0)
- Building clinical pharmacology laboratory capacity in low- and middle-income countries: Experience from Uganda (2023) (0)
- A training for health care workers to integrate hepatitis B care and treatment into routine HIV care in a high HBV burden, poorly resourced region of Uganda: the ‘2for1’ project (2022) (0)
- Association of Condom Use Advocacy with Perceived Condom Use Among Social Network Members: The Mediating Role of Advocates’ Internalized HIV Stigma and Own Condom Use (2022) (0)
- Evaluation of trypan blue stain in a haemocytometer for rapid detection of cerebrospinal fluid sterility in HIV patients with cryptococcal meningitis (2017) (0)
- Next-generation sequencing (NGS) reveals low-abundance HIV-1 drug resistance mutations among patients experiencing virological failure at the time of therapy switching in Uganda (2022) (0)
- A105 Virologic versus immunologic monitoring and the rate of accumulated genotypic resistance to first-line antiretroviral drugs in Uganda (2013) (0)
- Prospective evaluation of radiographic manifestations of tuberculosis in relationship with CD4 count in patients with HIV/AIDS (2023) (0)
- “You would not be in a hurry to go back home”: patients’ willingness to participate in HIV/AIDS clinical trials at a clinical and research facility in Kampala, Uganda (2020) (0)
- A training for health care workers to integrate hepatitis B care and treatment into routine HIV care in a high HBV burden, poorly resourced region of Uganda: the ‘2for1’ project (2022) (0)
- Intractable Chronic Vulval Ulceration Presenting as Immune Reconstitution Inflammatory Syndrome in a Treatment-Failure Patient: A Case Observation (2011) (0)
This paper list is powered by the following services:
Other Resources About Andrew Kambugu
What Schools Are Affiliated With Andrew Kambugu?
Andrew Kambugu is affiliated with the following schools:
